CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,298,000 | -17.1% | 50,541 | -3.7% | 0.16% | -23.3% |
| Q1 2018 | $2,772,000 | +269.6% | 52,500 | +775.0% | 0.20% | +648.1% |
| Q4 2017 | $750,000 | -95.7% | 6,000 | -97.2% | 0.03% | -97.5% |
| Q3 2017 | $17,457,000 | +32.7% | 211,851 | +50.7% | 1.10% | +39.1% |
| Q2 2017 | $13,160,000 | +350.4% | 140,558 | +206.2% | 0.79% | +282.6% |
| Q1 2017 | $2,922,000 | – | 45,900 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |